Since H. pylori- infected patients showed variations in the clinical manifestations such as gastritis, peptic ulcers, and gastric cancer, reporting the CagA prevalence on a range of gastric disorders is of immense value. This evidence concerns the gene S100A8 and peptic ulcer disease.